Jan Nilsson

Président chez ANNEXIN PHARMACEUTICALS AB

Profil

Jan Nilsson currently works at Annexin Pharmaceuticals AB, as Chairman from 2024, CCRM Nordic AB, as Chairman, CanImGuide Therapeutics AB, as Non-Executive Director, Panion Animal Health AB, as Director from 2019, Urbicum Ledningskonsult AB, as Director, CarryGenes Therapeutics AB, as Director, and Immodulate Pharma AB, as Director.
Mr. Nilsson also formerly worked at Promore Pharma AB, as Chief Executive Officer & Director from 2011 to 2013, CombiGene AB, as Chief Executive Officer & Director, Abliva AB, as Chief Operating Officer in 2016, and Pergamum AB, as Chief Commercial Officer.
Mr. Nilsson received his Masters Business Admin degree from the University of Uppsala and graduate degree from the University of Gothenburg.

Postes actifs de Jan Nilsson

Sociétés	Poste	Début
ANNEXIN PHARMACEUTICALS AB	Président	01/01/2024
CanImGuide Therapeutics AB	Directeur/Membre du Conseil	-
Urbicum Ledningskonsult AB	Directeur/Membre du Conseil	-
CarryGenes Therapeutics AB	Directeur/Membre du Conseil	-
Immodulate Pharma AB	Directeur/Membre du Conseil	-

Anciens postes connus de Jan Nilsson

Sociétés	Poste	Fin
Panion Animal Health AB	Directeur/Membre du Conseil	08/08/2025
COMBIGENE AB	Directeur Général	01/09/2023
ABLIVA AB	Directeur Général	14/03/2016
Promore Pharma AB	Directeur Général	01/01/2013
░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-